Spinal cord organoids from SMA patients reveal widespread neurodevelopmental defects. Single-cell and functional analyses show global dysregulation, which can be rescued by SMN-increasing therapy, stressing the importance of timely intervention.
- Irene Faravelli
- Paola Rinchetti
- Stefania Corti